Skip to content

Can Ozempic Replace Exercise? Health Benefits You Lose Without Training

ozempic-and-exercise
Can Ozempic Replace Exercise? Health Benefits You Lose Without Training
Garett Reid

Written by  | NSCA, CSCS, CISSN, M.S.E.S.S

Fact checked by Tyler DiGiovanni

Ozempy, Wegovy, and Monjuro are all GLP-1 drugs for weight loss, and they're here to stay. Considering the long history of quick "30-day" weight loss miracle drugs, these medications are the first to deliver on what they promise, and they do it very, very well.

However, they're not exactly the miracle drug many present them as, a "set and forget" therapy where you just enjoy the benefits. In fact, this mindset is actually causing issues and forfeiting what seems to be the only true "miracle drug" we have.

Take Your Fitness To The Next Level

Using Ozempic without exercise and resistance training is setting you up for failure. 

Key Points You Need To Know!

  • GLP-1 medications are indicated as "adjunct medications" to diet and exercise to improve glycemic control and weight loss
  • GLP-1 medications offer health benefits if used alone, but don't replace the benefits of exercise 
  • GLP-1 can cause elevated rates of muscle loss and bone loss.
  • Diet and exercise not only enhance the effects of GLP-1 medications but also offer unique benefits crucial for health and longevity.
  • Strength and endurance training improve essential health benefits such as immunity, brain health, cognition, increase BMD, metabolic function, and quality of life.

Should Ozempic And GLP-1 Medications Replace Exercise?

No. Absolutely not.

In fact, GLP-1 medications are labeled as an "adjunct medication" to exercise and diet (Eli Lilly and Company, n.d.). This means GLP-1 medication is a secondary medication designed to support the primary therapy.

While it is not mandatory for doctors to prescribe exercise (another discussion entirely), it doesn't diminish the role of exercise in living a healthy life. Removing exercise negates a host of benefits and increases your risk of long-term health problems.

Despite this, many people choose to use these medications as solo therapies without a workout plan. While it works great for fat loss (maybe too great), this is a mistake. Consider:

1. It treats weight loss as the only reason we train. Even though weight loss has been the primary reason people go to the gym, burning fat is just one of the benefits of training.

2. It negates the numerous other benefits of exercise. Exercise and resistance training provide benefits that cannot be replicated by pharmaceutical interventions, such as building your immune system and improving functional fitness (Rogeri et al., 2020).

3. It sets people up for a lifetime of pharmaceutical intervention. Medications can be powerful tools. However, the ultimate goal should be temporary, serving to guide a patient toward healthy interventions.  Without exercise and lifestyle interventions, the patient is signing up for lifelong pharmaceutical interventions.

4. It increases the risk of negative side effects of Ozempic use. Ozempic itself can cause side effects. Some of the most commonly reported issues, such as severe muscle loss, can be easily mitigated with resistance training.

Resistance Training And Cardio Are More Than Burning Calories

The biggest problem around training and fat loss is the hyper-focus on fat loss. Of course, this will happen and is a major benefit when done right; that's why we have our own programs that utilize both fat loss and resistance training to maximize results!

However, fat loss is just one of many health benefits.

Stripping exercise down to a tool to burn calories drastically undervalues the importance of an active lifestyle.

Why Ozempic And GLP-1 Can't Replace Exercise

Here are the reasons why Ozemplic and GLP-1s should almost always be used in conjunction with a proper training program. 

1. Ozempic And GLP-1 Medications Can Increase Muscle Loss

One of the most widely reported side effects of using GLP-1s is increased risk of muscle mass loss. This is because your body may break down muscle tissue to access amino acids for energy during weight loss.

However, this isn't unique to Ozempic; it's just magnified.

Whenever you get into a caloric deficit, you're at risk of losing muscle mass. This is one of the reasons why we always recommend weight training with a diet.

The issue with muscle loss and Ozempic is that the caloric deficit is usually significantly greater than that with a normal weight-loss diet. As a result, you lose muscle mass at a significantly higher rate than on a normal diet.

Studies show that muscle mass can account for up to 40% of weight loss; that's at least twice as much as normal diets (McCrimmon et al., 2020)!

But this can be mitigated, as it is in normal weight-loss situations, with resistance training.

We go into this in much more detail in this article, so check it out!

2. Ozempic Doesn't Increase Bone Strength 

Another very important benefit of resistance training is increasing bone strength. Your bones can grow stronger through a similar cycle to muscle growth.

Apply Loading To The Bone → Stress Triggers Bone Growth → Stronger And Thicker Bones.

You can apply stress to the bones through various methods. However, resistance training is the best and most complete method.

Research shows that resistance training with proper loads can increase bone mineral density in almost every bone in the body (Massini et al., 2022).

  • Leg bones
  • Spinal column
  • Arms

Unlike our training programs, Ozempic puts 0 strain on your bones. In fact, while direct studies are limited, the ones we do have show GLP-1 medication can actually cause bone loss (Karem et al., 2025).

3. Risk Reduction vs Physical Capacity

Semaglutide and other GLP-1 medications alone are able to improve metabolic parameters such as; 

  • Blood glucose control
  • Insulin sensitivity 
  • Risk markers for heart disease

These are largely due to fat loss and improved eating habits. Due to the large caloric deficits, initial weight loss typically occurs much faster than exercise and diet alone, making it an important benefit for many at-risk patients.

However, these improvements do not translate into things like;

All of these are independent predictors of mortality and functional independence, increasing resilience against chronic disease progression (Ross et al., 2017).

Ozempic alone can improve several fitness markers, but it does not provide the full spectrum of health benefits that resistance training and physical activity do.

4. Exercise Acts As Neuroprotection and Increases Brain Health

One of the more interesting yet unknown benefits of exercise, particularly cardio, is that it acts as a powerful neural protector.

Exercise stimulates neurobiological pathways critical for cognitive health and induces significant increases in brain-derived neurotrophic factor (BDNF). BDNF is a protein essential for neuroplasticity, neuronal survival, and improved memory and mood.

Increases in from exercise are positively correlated with:

  • Enhanced hippocampal neurogenesis,
  • Improved synaptic plasticity,
  • Stronger cognitive control and working memory (Erickson et al., 2014).

Exercise not only protects your muscles but your brain as well (Vecchio et al., 2018).

Improving glucose control can have a positive effect on cognitive and brain health, but it's essentially bringing risk down to baseline rather than building protection. 

5. Muscle Is An Endocrine Organ

In addition to manipulating your skeletal system, muscles function as an endocrine organ (Pedersen & Febbraio, 2012).

When stimulated through contractions, your muscle releases a class of signaling compounds called myokines (Pedersen, 2019). These myokines have systemic effects on 

  • Metabolic regulation
  • Inflammation
  • Brain health.

Physical activity drives the production and release of these beneficial molecules, which are exercise-specific signals. GLP-1 drugs do not reproduce this signaling environment.

At the same time, muscle mass is where you store glucose and plays a crucial role in insulin sensitivity.

Low muscle mass has now been shown to be an independent risk factor for diabetes, regardless of fat mass (Sun et al., 2017). If your body has nowhere to store glucose, it stays in your bloodstream, resulting in high blood sugar.

Not only does GLP-1 not provide these benefits, but it can also actually cause a decrease in muscle mass, as we saw above. Proper strength training to build mass is the only tool we have to counteract this.

6. Quality Of Life and Functional Independence

Aging isn't just about disease incidence but the loss of functional capacity as well. Maintaining independence and the ability to perform everyday tasks is a benefit you don't realize until it's gone.

This functional decline is caused by;

  • Loss of muscle mass and strength (sarcopenia)
  • Declines in bone density
  • Reduced physical performance
  • Decreased cognition

All of these can be mitigated and improved with proper resistance training.

Exercising and being active is about so much more than looking good or shedding pounds; it's the only tool we have to maintain quality of life as we age.

So while GLP-1 drugs can lower the risk of certain diseases and improve certain health markers, physical training builds capacity, which determines the quality of life.

The difference between longevity and lifespan is critical. While semaglutide reduces risk markers and may statistically lower mortality risk, that insight does not guarantee improved quality of life, especially as you age (Ruiz et al., 2008).

Can Ozempic and Exercise Work Together?

Ozempic and GLP-1 therapies have obviously proven to be highly effective tools in weight loss. But they don't provide the benefits that training does.

Resistance training and aerobic exercise help limit muscle loss, preserve strength, and enhance body composition during pharmacological weight loss.

Combining these drugs with exercise is not a hypothetical "best practice" but is rooted in basic physiology and supported by accumulating evidence:

  • Physical activity enhances functional health outcomes that medications do not.
  • Resistance exercise helps preserve and build muscle mass, which would otherwise decline during GLP-1–induced weight loss.

The most successful strategies for long-term metabolic health and physical capacity aren't relying on one tool but rather an all-encompassing strategy:

  • Resistance training
  • Diet and Supplementation 
  • Active lifestyle
  • Proper sleep and recovery 
  • Proper pharmaceutical intervention, if appropriate 

Conclusion: Exercise And GLP-1s

There shouldn't be tension between exercise and GLP-1s, nor should it be an either/or discussion. These medications are intended to be used alongside exercise and a healthy diet.

GLP-1 drugs like Ozempic help to quickly decrease weight and improve risk markers. This makes it an effective tool for the right individual to help manage metabolic disease and reduce cardiovascular events.

Improving your fitness lifestyle, increasing physical activity, and learning healthy eating will ultimately maximize your health. This includes improving your strength, immune system, cognition, and functional independence that will carry you through your entire life.

If you need help with developing a program, contact us, and we'd love to help you out so you can see results that will last a lifetime

Ozempic And Exercise FAQ

Does Ozempic replace exercise?

No. Ozempic reduces the risk of metabolic and cardiovascular disease, but it does not improve VO₂ max, muscle strength, bone density, balance, brain plasticity, or functional independence.  These adaptations primarily occur through physical activity, making it the only path to long-term longevity.

Can you get cardiovascular benefits from Ozempic without working out?

Yes, in terms of reduced heart attack and stroke risk. But it does not improve cardiovascular fitness, endurance, or physical work capacity.

Does Ozempic cause muscle loss?

Some weight loss with GLP-1 drugs can be due to lean mass loss. Without resistance training and adequate protein, users may lose muscle and strength over time (Wilding et al., 2021).

Is Ozempic good for brain health?

GLP-1 drugs may reduce neuroinflammation, but exercise uniquely increases BDNF, cerebral blood flow, and cognitive resilience (Vecchio et al., 2018).

References

  1. Ekelund, U., Tarp, J., Steene-Johannessen, J., Hansen, B. H., Jefferis, B., Fagerland, M. W., Whincup, P., Diaz, K. M., Hooker, S. P., Chernofsky, A., Larson, M. G., Spartano, N. L., Vasan, R. S., Dohrn, I.-M., Hagströmer, M., & Lee, I.-M. (2019). Dose-response associations between accelerometry-measured physical activity and sedentary time and all-cause mortality. BMJ, 366, l4570. https://doi.org/10.1136/bmj.l4570
  2. Eli Lilly and Company. (n.d.). Mounjaro® (GIP and GLP-1 receptor agonist for T2D). Retrieved February 9, 2026, from https://mounjaro.lilly.com/hcp
  3. Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., & Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022. https://doi.org/10.1073/pnas.1015950108
  4. Howe, T. E., Shea, B., Dawson, L. J., Downie, F., Murray, A., Ross, C., Harbour, R. T., Caldwell, L. M., & Creed, G. (2011). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews, (7), CD000333. https://doi.org/10.1002/14651858.CD000333.pub2
  5. McCrimmon, R. J., Catarig, A. M., Frias, J. P., Lausvig, N. L., le Roux, C. W., Thielke, D., & Lingvay, I. (2020). Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial. Diabetologia, 63(3), 473–485. https://doi.org/10.1007/s00125-019-05065-8
  6. Karam, L., Mabilleau, G., & Paccou, J. (2025). Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 36(11), 2115–2126. https://doi.org/10.1007/s00198-025-07664-1 
  7. Pedersen, B. K. (2019). Physical activity and muscle–brain crosstalk. Nature Reviews Endocrinology, 15(7), 383–392. https://doi.org/10.1038/s41574-019-0174-x 
  8. Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nature Reviews Endocrinology, 8(8), 457–465. https://doi.org/10.1038/nrendo.2012.49
  9. Massini, D. A., Nedog, F. H., de Oliveira, T. P., Almeida, T. A. F., Santana, C. A. A., Neiva, C. M., Macedo, A. G., Castro, E. A., Espada, M. C., Santos, F. J., & Pessôa Filho, D. M. (2022). The Effect of Resistance Training on Bone Mineral Density in Older Adults: A Systematic Review and Meta-Analysis. Healthcare (Basel, Switzerland), 10(6), 1129. https://doi.org/10.3390/healthcare10061129
  10. Rogeri, P. S., Gasparini, S. O., Martins, G. L., Costa, L. K. F., Araujo, C. C., Lugaresi, R., Kopfler, M., & Lancha, A. H., Jr (2020). Crosstalk Between Skeletal Muscle and Immune System: Which Roles Do IL-6 and Glutamine Play?. Frontiers in physiology, 11, 582258. https://doi.org/10.3389/fphys.2020.582258
  11. Ross, R., Blair, S. N., Arena, R., Church, T. S., Després, J.-P., Franklin, B. A., Haskell, W. L., Kaminsky, L. A., Levine, B. D., Lavie, C. J., Myers, J., Niebauer, J., & Sallis, R. (2016). Importance of assessing cardiorespiratory fitness in clinical practice: A case for fitness as a clinical vital sign. Circulation, 134(24), e653–e699. https://doi.org/10.1161/CIR.0000000000000461
  12. Ruiz, J. R., Sui, X., Lobelo, F., Morrow, J. R., Jackson, A. W., Sjöström, M., & Blair, S. N. (2008). Association between muscular strength and mortality in men: Prospective cohort study. BMJ, 337, a439. https://doi.org/10.1136/bmj.a439
  13. Son, J. W., Lee, S. S., Kim, S. R., Yoo, S. J., Cha, B. Y., Son, H. Y., & Cho, N. H. (2017). Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia, 60(5), 865–872. https://doi.org/10.1007/s00125-016-4196-9
  14. Vecchio, L. M., Meng, Y., Xhima, K., Lipsman, N., Hamani, C., & Aubert, I. (2018). The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging. Brain plasticity (Amsterdam, Netherlands), 4(1), 17–52. https://doi.org/10.3233/BPL-180069 
  15. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

0 comments

Leave a comment

Please note, comments need to be approved before they are published.